BRIACELL THERAPEUTICS CORP's ticker is BCTX and the CUSIP is 10778Y302. A total of 27 filers reported holding BRIACELL THERAPEUTICS CORP in Q3 2022. The put-call ratio across all filers is 0.08 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2022 | $101,000 | +9.8% | 17,900 | +12.6% | 0.01% | 0.0% |
Q2 2022 | $92,000 | -34.8% | 15,900 | +14.4% | 0.01% | -20.0% |
Q1 2022 | $141,000 | -25.8% | 13,900 | -39.3% | 0.01% | -28.6% |
Q4 2021 | $190,000 | +21.0% | 22,900 | +18.0% | 0.01% | -36.4% |
Q3 2021 | $157,000 | – | 19,400 | – | 0.02% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Redmond Asset Management, LLC | 136,593 | $1,106,000 | 0.35% |
Total Clarity Wealth Management, Inc. | 11,425 | $93,000 | 0.04% |
Virtu Financial LLC | 32,952 | $267,000 | 0.02% |
Apollon Wealth Management, LLC | 19,400 | $157,000 | 0.02% |
Summit Trail Advisors, LLC | 35,000 | $284,000 | 0.02% |
FNY Investment Advisers, LLC | 4,687 | $37,000 | 0.02% |
Freedom Investment Management, Inc. | 16,649 | $135,000 | 0.01% |
VOLORIDGE INVESTMENT MANAGEMENT, LLC | 156,946 | $1,271,000 | 0.01% |
Belvedere Trading LLC | 13,608 | $107,000 | 0.00% |
GOFEN & GLOSSBERG LLC /IL/ | 10,000 | $81,000 | 0.00% |